|
Name |
(6,16-diacetoxy-25-hy- droxy-3,7-dioxy-29-nordammara-1,17(20)-dien-21-oic acid
|
| Molecular Formula | C31H42O6 | |
| IUPAC Name* |
2-(16-acetyloxy-4,8,10,14-tetramethyl-3,7-dioxo-5,6,9,11,12,13,15,16-octahydro-4H-cyclopenta[a]phenanthren-17-ylidene)-6-methylhept-5-enoicacid
|
|
| SMILES |
CC(=O)OC1CC2(C)C(CCC3C4(C)C=CC(=O)C(C)C4CC(=O)C32C)C1=C(CCC=C(C)C)C(=O)O
|
|
| InChI |
InChI=1S/C31H42O6/c1-17(2)9-8-10-20(28(35)36)27-21-11-12-25-29(5)14-13-23(33)18(3)22(29)15-26(34)31(25,7)30(21,6)16-24(27)37-19(4)32/h9,13-14,18,21-22,24-25H,8,10-12,15-16H2,1-7H3,(H,35,36)/b27-20-/t18-,21-,22-,24-,25-,29-,30-,31+/m0/s1
|
|
| InChIKey |
BUGCTTLZUIPSGV-JASSQNIFSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 510.67 | ALogp: | 5.9 |
| HBD: | 1 | HBA: | 5 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 97.7 | Aromatic Rings: | 4 |
| Heavy Atoms: | 37 | QED Weighted: | 0.278 |
| Caco-2 Permeability: | -5.285 | MDCK Permeability: | 0.00002050 |
| Pgp-inhibitor: | 0.548 | Pgp-substrate: | 0.042 |
| Human Intestinal Absorption (HIA): | 0.057 | 20% Bioavailability (F20%): | 0.581 |
| 30% Bioavailability (F30%): | 0.746 |
| Blood-Brain-Barrier Penetration (BBB): | 0.995 | Plasma Protein Binding (PPB): | 96.58% |
| Volume Distribution (VD): | 0.539 | Fu: | 5.03% |
| CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.115 |
| CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.827 |
| CYP2C9-inhibitor: | 0.055 | CYP2C9-substrate: | 0.211 |
| CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.058 |
| CYP3A4-inhibitor: | 0.384 | CYP3A4-substrate: | 0.285 |
| Clearance (CL): | 5.04 | Half-life (T1/2): | 0.215 |
| hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.23 |
| Drug-inuced Liver Injury (DILI): | 0.05 | AMES Toxicity: | 0.004 |
| Rat Oral Acute Toxicity: | 0.269 | Maximum Recommended Daily Dose: | 0.817 |
| Skin Sensitization: | 0.047 | Carcinogencity: | 0.594 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.065 |
| Respiratory Toxicity: | 0.97 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003780 | ![]() |
0.802 | D0X7XG | ![]() |
0.523 | ||
| ENC001480 | ![]() |
0.748 | D0G7KJ | ![]() |
0.297 | ||
| ENC005487 | ![]() |
0.730 | D09WYX | ![]() |
0.290 | ||
| ENC003484 | ![]() |
0.661 | D01ZOG | ![]() |
0.289 | ||
| ENC002467 | ![]() |
0.625 | D0X2LV | ![]() |
0.284 | ||
| ENC005236 | ![]() |
0.615 | D0D2TN | ![]() |
0.284 | ||
| ENC005154 | ![]() |
0.615 | D08BDT | ![]() |
0.280 | ||
| ENC003848 | ![]() |
0.598 | D09IEE | ![]() |
0.275 | ||
| ENC003846 | ![]() |
0.543 | D03SXE | ![]() |
0.273 | ||
| ENC001478 | ![]() |
0.523 | D0X4RS | ![]() |
0.271 | ||